What is DIANOSIC SAS?
Founded in 2017 and headquartered in France, DIANOSIC SAS is a deeptech company specializing in solutions for Ear, Nose, and Throat (ENT) conditions. The company leverages advanced technology to address unmet needs within this medical specialty. Its focus on a specific niche within healthcare positions it as a key player in developing innovative diagnostic and therapeutic tools for ENT specialists and patients alike.
How much funding has DIANOSIC SAS raised?
DIANOSIC SAS has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2023): $5M with participation from Bpifrance and WiSEED
Key Investors in DIANOSIC SAS
Bpifrance
Bpifrance is a French public investment bank that finances companies across all stages of development, providing credit, guarantees, and equity. They also support innovation, international expansion, and offer consulting and acceleration programs for businesses.
WiSEED
WiSEED is a French crowdfunding platform that enables private investors to directly invest in innovative and technological startups, offering a new horizon for investments in sustainable and performance-driven companies.
What's next for DIANOSIC SAS?
With the recent major strategic investment, DIANOSIC SAS is well-positioned for its next phase of development and market expansion. This capital injection is expected to fuel research and development initiatives, enhance product commercialization efforts, and potentially broaden the company's market reach. The strategic nature of this financing suggests a strong alignment between DIANOSIC SAS and its backers, pointing towards a future focused on scaling operations and solidifying its position in the competitive deeptech healthcare landscape.
See full DIANOSIC SAS company page
